Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Michl

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
The Journal of Pathology|June 25, 2013
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersAntje Krohn, Annemarie Seidel, Lia Burkhardt, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Oncotarget|February 2, 2017
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
European Urology|November 27, 2016
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal TherapyMeike Adam, Pierre Tennstedt, Dominik Lanwehr, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
The Journal of Pathology|June 25, 2013
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersAntje Krohn, Annemarie Seidel, Lia Burkhardt, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Oncotarget|February 2, 2017
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
European Urology|November 27, 2016
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal TherapyMeike Adam, Pierre Tennstedt, Dominik Lanwehr, et al.
BJU International|August 2, 2006
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validationFelix K-H Chun, Alberto Briganti, Shahrokh F Shariat, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
Pageof 7